Research on revision of origins to Chinese medicinal materials in 2020 edition of Chinese pharmacopoeia / 中国中药杂志

The origins of 9 species of the Chinese medicinal materials in the 2015 edition of the Chinese pharmacopoeia(ChP) has revised in the 2020 edition of ChP. The revision is based on the investigation and textual research on the problems found after screening the original plants, animals or minerals of all the Chinese medicinal materials in the 2015 edition. Among them the Chinese names of Alismatis Rhizoma, Cassiae Semen, Coicis Semen, Corydalis Bungeanae Herba and Echinopsis Radix all do not match to the Latin scientific names, and also do not match the name of the actual medicinal origins. In addition, Alismatis Rhizoma has the omission of original plant. There is confusion about the Chinese name and the family name of the original insect of Cera Chinensis. The original mineral of Gypsum Fibrosum has the wrong group names. Alumstone and melanterite, the original mineral of Alumen and Melanteritum respectively, of which the group names are missing. To solve these problems, field survey and literature research were conducted on the medicinal materials and their origins. The source of these problems are explored. The correct origins and the Chinese names or Latin names are all determined according to the research results to the situation, in which the Chinese and Latin names of the original plants of the medicinal materials do not match. The correct family name and group name are obtained through textual research by taxonomy if the names are confused or mis-sing. The scientific evidence and correct results of revision in the 2020 edition of ChP are determined at last.

Study on original plant species and geographical distribution of Fructus Aurantii / 中国中药杂志

The original plant species of Fructus Aurantii are multitudinous and complex, and their requirements to the growing environment is strict. In order to clarify the original plant species and geographical distribution of Fructus Aurantii which recorded in the standards and circulated, used in commodity. The national and local standards of Chinese medicinal materials were collected and the original plants of Fructus Aurantii recoded in standards were found. Ten original plant species of Fructus Aurantii (including varieties of cultivars, the same below) were recorded in the Chinese pharmacopoeia and six local standards of Zhejiang, Yunnan and Guizhou etc. The producing areas and commodity in markets of Fructus Aurantii were investigated. The growth environment and geographical distribution of them were analyzed. There are six types of Fructus Aurantii i.e., Fructus Aurantii Chuan, Fructus Aurantii Xiang, Fructus Aurantii Jiang, Fructus Aurantii Qu, Fructus Aurantii Su, Fructus Aurantii Wen, and nineteen species of original plants in the practical commodities. There are four major Fructus Aurantii producing areas: Sichuan Basin, Dongting Lake Plain, Poyang Lake Plain, Jinqu Basin and its surrounding hilly areas. All of them are located in the area of the east longitude 104° to 121° and the northern latitudes 27° to 31°. There is a certain difference between the actual commodity and the standards of medicinal materials. It is suggested that the traditional mainstream types of Fructus Aurantii with fine quality should be accepted into Chinese Pharmacopoeia, and the types with poor quality should be withdrawn from Chinese Pharmacopoeia.

Determination of ginsenosides Re, Rb1 in Panax quinquefolius by micellar electrokinetic chromatography / 中国中药杂志

<p><b>OBJECTIVE</b>A Micellar electrokinetic chromatography (MEKC) technique for the determination of ginsenosides Re, Rb1 in Panax quinquefolius was developed and validated.</p><p><b>METHOD</b>The MEKC was performed in a mixed buffer solution containing 20 mmol x L(-1) boric acid, 20 mmol x L(-1) sodium tetraborate, 60 mmol x L(-1) sodium cholate (CA) and 20% acetonitrile under the applied voltage of 20 kV at 25 degrees C. The detection wavelenth was 203 nm, the sampling time is 5 sec (hydrostatic injection).</p><p><b>RESULT AND CONCLUSION</b>The liner range was 0.38 - 1.65 mg x ml(-1) for Re and 0.42 - 1.76 g x L(-1) for Rb1. The average recovery for Re was 97.2%, RSD = 1.6% and that for Rb1 was 97.7%, RSD = 1.9% (n = 5). The preparation of sample is easy and the chromatogram has much information.</p>